Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Neoplasms 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Lymphoma 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Carcinoma, Squamous Cell 2Brain Neoplasms 2Adenocarcinoma 2Urticaria 1Tuberous Sclerosis 1Thrombosis 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Small Cell Lung Carcinoma 1Severe Combined Immunodeficiency 1Sarcoma 1Salivary Gland Neoplasms 1Renal Insufficiency, Chronic 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Dysautonomias 1Polycythemia Vera 1Polycythemia 1Polycystic Ovary Syndrome 1Pancreatitis, Chronic 1Pancreatitis 1Pancreatic Cyst 1Ovarian Neoplasms 1

Interventions

pembrolizumab 1ficlatuzumab 1durvalumab 1Radiotherapy, Intensity-Modulated 1Phlebotomy 1Metabolic Flux Analysis 1Cisplatin 1Cetuximab 1Carboplatin 1Blood Specimen Collection 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lip Neoplasms × Phlebotomy × Clear all
NCT00568490 2025-07-02

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

Stanford University

Recruiting
200 enrolled
Head & NeckThoracic

Head and Neck Neoplasms, Lip Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡